Erythromycin Ethylsuccinate For Suspension
Product Images NDC 71209-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin Ethylsuccinate (NDC 71209-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cadila-cont-label-200mg-5ml.jpg (Cadila Cont Label 200mg 5ml)

This appears to be a prescription label for Erythromycin Ethylsuccinate for Oral Suspension, USP which contains 200 mg per 5 mL of Erythromycin. The suggested dosage is 150 mg per kg to be administered without regard to meals. The label also includes a registration number for the product and contact information for the manufacturer.*

FDA Label Image

Cadila-cont-label-400mg-5ml.jpg (Cadila Cont Label 400mg 5ml)

This appears to be a description of a medication called Erythromycin Ethylsuccinate for Oral Suspension, USP. It is a liquid medication that contains 400mg of Erythromycin per 5mL. The medication comes in a bottle and must be reconstituted before use. There are also listed batch numbers and other technical information that may not be relevant to a general description.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.